It poses diagnostic challenges in day-to-day practice in misdiagnosis of tumor-like lesions and secondary tumors. This book is a concise, practical guide to prostate pathology and is structured to ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration to integrate its prostate ...

BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

Paige Prostate, a first-in-class software solution ... Paige has rapidly become a reference in the field of digital pathology through a number of firsts, including first FDA breakthrough ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

Hirst III Professors of Oncology in Pathology and members of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. The scientists found that the absence of a protein called PKCλ/ι in ...

immunopathology and urological pathology. He has provided tissue biopsy and clinical laboratory diagnoses, prognoses and therapeutic advice to patients and clinicians on medical and surgical diseases ...

Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the leader in ...